Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Cyclophosphamide followed by intravenous targeted busulfan for allogeneic hematopoietic cell transplantation: pharmacokinetics and clinical outcomes
Rheumatol Int (2017) 37(1):2942
Soto, J
, 75 , 323-334, doi: Terzyan, S
An ever-expanding field of recombinant DNA technology has developed to achieve this goal, allowing for the design or modification and production of high-yield proteins
Holter monitoring studies have shown that more than two-thirds of ischemic episodes occur during daily activities, without anginal symptoms (174)
US$ 21.65
US$ 26.11
US$ 26.85
![Base Set Complete Master Set (102/102) 1999 [MP-DMG]](https://tradingcardsets.com/cdn/shop/files/IMG-1055_436x436.png?v=1701900395)
